Effects of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on cancer therapy-related cardiac dysfunction: a meta-analysis of randomized controlled trials
出版年份 2020 全文链接
标题
Effects of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on cancer therapy-related cardiac dysfunction: a meta-analysis of randomized controlled trials
作者
关键词
-
出版物
HEART FAILURE REVIEWS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-03
DOI
10.1007/s10741-019-09906-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity
- (2019) Allison Padegimas et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Immune Checkpoint Inhibitors–Related Cardiotoxicity
- (2019) Venu Madhav Konala et al. AMERICAN JOURNAL OF THERAPEUTICS
- The Preventive Role of ACE Inhibitors/Angiotensin-II Receptor Blockers and β–Adrenergic Blockers in Anthracycline and Trastuzumab-Induced Cardiotoxicity.
- (2019) Julia B. Blanter et al. Cardiology in Review
- Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
- (2019) Maya Guglin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of prophylactic betablocker or ACE inhibitor on cardiac dysfunction & heart failure during anthracycline chemotherapy ± trastuzumab
- (2018) Dorothy M. Gujral et al. BREAST
- Renin–Angiotensin System Inhibitors to Mitigate Cancer Treatment–Related Adverse Events
- (2018) Matthias Pinter et al. CLINICAL CANCER RESEARCH
- Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial
- (2018) Vineeta Gupta et al. PEDIATRIC BLOOD & CANCER
- Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
- (2018) Jessica Marinello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heart failure in cancer: role of checkpoint inhibitors
- (2018) Murilo Delgobo et al. Journal of Thoracic Disease
- Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
- (2017) Peter A Henriksen HEART
- Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT1 R upregulation are required for doxorubicin-induced cardiotoxicity
- (2017) Chih-Yang Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
- (2017) Edith Pituskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
- (2017) Carlos M. Ferrario et al. PHARMACOLOGICAL RESEARCH
- Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity
- (2016) Stefano Taddei et al. American Journal of Cardiovascular Drugs
- Trastuzumab cardiotoxicity: from clinical trials to experimental studies
- (2016) Balazs T Nemeth et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy
- (2016) Ghasem Janbabai et al. Cardiovascular Toxicology
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
- (2016) Geeta Gulati et al. EUROPEAN HEART JOURNAL
- Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer
- (2016) Annelies H. Boekhout et al. JAMA Oncology
- Bradykinin in ischemic conditioning-induced tissue protection: Evidences and possible mechanisms
- (2015) Roohani Sharma et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis
- (2015) Seongseok Yun et al. POSTGRADUATE MEDICAL JOURNAL
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis
- (2013) Kashif Kalam et al. EUROPEAN JOURNAL OF CANCER
- The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress
- (2013) Taija S. Koskenkorva-Frank et al. FREE RADICAL BIOLOGY AND MEDICINE
- A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure
- (2012) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
- (2010) Christian Cadeddu et al. AMERICAN HEART JOURNAL
- Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: A prospective, parallel-group, randomized, controlled study with 36-month follow-up
- (2010) Peter Georgakopoulos et al. AMERICAN JOURNAL OF HEMATOLOGY
- Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function
- (2010) Asimina Hiona et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started